Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors

Nutrition and Cancer

Volumn 62, Issue 6, 2010, Pages 734-742

  Malik, Manzoor Ahmad ^a   Upadhyay, Rohit ^a   Mittal, Rama Devi ^a   Zargar, Showket Ali ^b   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 2E1; DRUG METABOLIZING ENZYME; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE M3; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; UNCLASSIFIED DRUG; XENOBIOTIC METABOLIZING ENZYME;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHI SQUARE TEST; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SMOKING; TEA;

ADULT; AGED; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2E1; ENVIRONMENT; ESOPHAGEAL NEOPLASMS; FEMALE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; XENOBIOTICS;

NICOTIANA TABACUM;

EID: 77954967552     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581003605904     Document Type: Article

References (52)

1. Tisigris C, Chatzitheoiylaktou A, Airomeritis C, Nikiteas N, and Yannopoulos A: Genetic association studies in digestive system malignancies. Anticancer Res 27, 3577-3587, 2007.
2. Parkin DM, Bray F, Ferlay J, and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55, 74-108, 2005.
3. Khuroo MS, Zargar SA, Mahajan R, and Banday MA: High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut 33, 11-15, 1992.
4. Siddiqi M, Tricker AR, and Preussmann R: The occurrence of preformed N nitroso compounds in food samples from a high risk area of esophageal cancer in Kashmir, India. Cancer Lett 39, 37-43, 1988.
5. Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, et al.: Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ 26, 338-b929, 2009.
6. Gonzalez FJ: The molecular biology of cytochrome P450s. Pharmacol Rev 40, 243-288, 1988.
7. Shi SF, Xie QX, and Li XB: The advance process in relation to the susceptibility of tumor. Guowai Yixue Zhongliuxue Fence 4, 304-307, 1988.
8. Cai L, Yu SZ, and Zhang ZF: Glutathione S-transferases M1, T1 genotypes and the risk of gastric cancer: a case-control study. World J Gastroenterol 7, 506-509, 2001.
9. Ali-Osman F, Akande O, Antoun G, Mao JX, and Buolamwini J: Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 272, 10004-10012, 1997.
10. Spink DC, Spink BC, Cao JQ, De Pasquale JA, Pentecost BT, et al.: Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 19, 291-298, 1998.
11. Hayashi S, Watanabe J, and Kawajiri K: Genetic polymorphisms in the 5′ flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 110, 559-565, 1991.
12. Shi Y, Lee JS, and Galvin KM: Everything you have ever wanted to know about Yin Yang 1. Biochim Biophys Acta 1332, 49-66, 1997.
13. Wideroff L, Vaughan TL, Farin FM, Gammon MD, Risch H, et al.: GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adeno- carcinomas. Cancer Detect Prev 31, 233-236, 2007.
14. Abbas A, Delvinquiere K, Lechevrel M, Lebailly P, Gauduchon P, et al.: GSTM1, GSTT1, GSTP1, and CYP1A1 genetic polymorphisms and susceptibility to esophageal cancer in a French population: different pattern of squamous cell carcinoma and adenocarcinoma. World J Gastroenterol 10, 3389-3393, 2004.
15. Martinez C, Martin F, Fernandez JM, Garcia-Martin E, Sastre J, et al.: Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics 7, 711-718, 2006.
16. Miller SA, Dykes DD, and Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16, 1215, 1988.
17. Setiawan VW, Zhang ZF, Yu GP, Li YL, Lu ML, et al.: GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population. Cancer Epidemiol Biomarkers Prev 9, 73-80, 2000.
18. Loktionov A, Watson MA, Gunter M, Stebbings WS, Speakman CT, et al.: Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk modulating factor. Carcinogenesis 22, 1053-1060, 2001.
19. Toriiner GA, Akyerli C, Ucar A, Aki T, Atsu N, et al.: Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population. Arch Toxicol 75, 459-464, 2001.
20. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, et al.: Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett 263, 131-133, 1990.
21. Hayashi S, Watanabe J, and Kawajiri K: Genetic polymorphisms in the 5′ flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 110, 559-565, 1991.
22. Gauderman WJ and Morrison JM: QUANTO 1.1. A computer program for power and sample size calculations for genetic-epidemiology studies. Available from: http://hydra.usc.edu/gxe, 2006.
23. Nelson HH, Wiencke JK, Christiani DC, Cheng TJ, Zuo ZF, et al.: Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis 16, 1243-1245, 1995.
24. Shao G, Su Y, Huang G, and Wen B: Relationship between CYP1A1, GSTM1 genetic polymorphisms and susceptibility to esophageal squamous cell carcinoma. Zhonghua Liuxing Bingxue Zazhi 21, 420-423, 2000.
25. Boccia SLa, Torre G, Gianfagna F, Mannocci A, and Ricciardi G: Metaanalysis of GSTT1 and gastric cancer. Mutagenesis 3, 1432-1435, 2006.
26. Tan W, Song N, Wang GQ, Liu Q, Tang HJ, et al.: Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol Biomarkers Prev 9, 551-556,2000.
27. Jourenkova-Mironova N, Voho A, Bouchardy C, Wikman H, Dayer P, et al.: Glutathione S-transferase GSTM3 and GSTP1 genotypes and larynx cancer risk. Cancer Epidemiol Biomarkers Prev 8, 185-188, 1999.
28. Park LY, Muscat JE, Kaur T, Schantz SP, Stern JC, et al.: Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians. Pharmacogenetics 10, 123-131, 2000.
29. Rannug A, Alexandrie AK, Persson I, and Ingelman-Sundberg M: Genetic polymorphism of cytochromes P450 1A1, 2D6 and 2E1: regulation and toxicological significance. J Occup Environ Med 37, 25-36, 1995.
30. Liu S, Park JY, Schantz SP, Stern JC, and Lazarus P: Elucidation of CYP2E1 5′ regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer. Oral Oncol 37, 437-445, 2001.
31. De SE, Boffetta P, Carzoglio J, Mendilaharsu S, and Deneo-Pellegrini H: Tobacco smoking and alcohol drinking as risk factors for stomach cancer: a case-control study in Uruguay. Cancer Cause Control 9, 321-329, 1998. (Pubitemid 28319024)
32. Available from: http://www.ncbi.nlm.nih.gov/projects/SNP/
33. Jain M, Kumar S, Rastogi N, Lal P, Ghoshal UC, et al.: GSTT1, GSTM1 and GSTP1 genetic polymorphisms and interaction with tobacco, alcohol, and occupational exposure in esophageal cancer patients from North India. Cancer Lett 242, 60-67, 1995, 2006.
34. Jain M, Kumar S, Lal P, Tiwari A, Ghoshal UC, et al.: Role of GSTM3 polymorphism in the risk of developing esophageal cancer. Cancer Epidemiol Biomarkers Prev 16, 178-181, 2007.
35. Sikdar N, Paul RR, and Roy B: Glutathione S-transferase M3 (A/A) genotype as a risk factor for oral cancer and leukoplakia among Indian tobacco smokers. Int J Cancer 109, 95-101, 2004.
36. Sikdar N, Mahmud SA, Paul RR, and Roy B: Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett 195, 33-42, 2003.
37. Sobti RC, Sharma S, Joshi A, Jindal SK, and Janmeja A: Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population. Mol Cell Biochem 266, 1-9, 2004.
38. Babu KA, Reddy NG, Deendayal M, Kennedy S, and Shivaji S: GSTM1, GSTT1, and CYP1A1 detoxification gene polymorphisms and their relationship with advanced stages of endometriosis in South Indian women. Pharmacogenet Genomics 15, 167-172, 2005.
39. Jain M, Kumar S, Ghoshal UC, and Mittal B: CYP1A1 Msp1 T/C polymorphism in esophageal cancer: no association and risk modulation. Oncol Res 16, 437-443, 2007.
40. Tripathi S, Ghoshal U, Ghoshal UC, Mittal B, Krishnani N, et al.: Gastric carcinogenesis: possible role of polymorphisms of GSTM1, GSTT1, and GSTP1 genes. Scand. J. Gastroenterol 43, 431-439, 2008.
41. Morita S,Yano M, Shiozaki H, Tsujinaka T, Ebisui C, et al.: CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 71, 192-195, 1997.
42. Harries LW, Stubbins MJ, Forman D, Howard GC, and Wolf CR: Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18, 641-644, 1997.
43. van-Lieshout EM, Roelofs H, Dekker S, Mulder CJ, Wobbes T, et al.: Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma. Cancer Res 59, 586-589, 1999.
44. Lan Q, Chow WH, Lissowska J, Hein DW, Buetow K, et al.: Glutathione S-transferase genotypes and stomach cancer in a population-based case- control study in Warsaw, Poland. Pharmacogenetics 11, 655-661, 2001.
45. Nakachi K, Imai K, Hayashi S, Watanabe J, and Kawajiri K: Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 51, 5177-5180, 1991.
46. Wu MS, Chen CJ, Lin MT, Wang HP, Shun CT, et al.: Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan. Int J Colorectal Dis 17, 338-343, 2002.
47. Marchand LL, Wilkinson GR, and Wilkens LR: Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone. Cancer Epidemiol Biomarkers Prev 8, 495-500, 1999.
48. Rossini A, Rapozo DC, Soares, Lima SC, Guimaraes DP, et al.: Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a Western population. Carcino- genesis 28, 2537-2542, 2007.
49. Siddiqi M, Kumar R, Fazili Z, Spiegelhalder B, and Preussmann R: Increased exposure to dietary amines and nitrate in a population at high risk of oesophageal and gastric cancer in Kashmir (India). Carcinogenesis 13, 1331-1335, 1992.
50. Siddiqi M, Tricker AR, and Preussmann R: Formation of N-nitroso compounds under simulated gastric conditions from Kashmir foodstuffs. Cancer Lett 39, 259-265, 1988.
51. Li Y, Zhang X, Huang G, Miao X, Guo L, et al.: Identification of a novel polymorphism Arg290Gln of esophageal cancer related gene 1 (ECRG1) and its related risk to esophageal squamous cell carcinoma. Carcinogenesis 27, 798-802, 2006.
52. van Leeuwen DM, van Agen E, Gottschalk RW, Vlietinck R, Gielen M, et al.: Cigarette smoke-induced differential gene expression in blood cells from monozygotic twin pairs. Carcinogenesis 28, 691-697, 2007.